{
    "root": "7875efff-59e3-4f68-84c5-e3c9c16d6a3c",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Zestril",
    "value": "20250102",
    "ingredients": [
        {
            "name": "LISINOPRIL",
            "code": "E7199S1YWR",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_43755"
        },
        {
            "name": "DIBASIC CALCIUM PHOSPHATE DIHYDRATE",
            "code": "O7TSZ97GEP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_77635"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_29864"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        }
    ],
    "indications": {
        "text": "zestril angiotensin converting enzyme ( ace ) inhibitor indicated : treatment hypertension adults pediatric patients 6 years age older ( 1.1 ) adjunct therapy heart failure ( 1.2 ) treatment acute myocardial infarction ( 1.3 )",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            },
            {
                "text": "acute myocardial infarction (DOID:9408)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9408"
            },
            {
                "text": "myocardial infarction (DOID:5844)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5844"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "acute myocardial infarction",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_95409"
            }
        ]
    },
    "contraindications": {
        "text": "hypertension : initial adult dose 10 mg daily . titrate 40 mg daily based blood pressure response . initiate patients diuretics 5 mg daily ( 2.1 ) pediatric patients glomerular filtration rate > 30 ml/min/1.73m 2 : initial dose patients 6 years age older 0.07 mg per kg ( 5 mg total ) daily ( 2.1 ) heart failure : initiate 5 mg daily . increase dose tolerated 40 mg daily ( 2.2 ) acute myocardial infarction ( myocardial infarction ) : give 5 mg within 24 hours myocardial infarction . followed 5 mg 24 hours , 10 mg daily ( 2.3 ) renal impairment : patients creatinine clearance \u2265 10 ml/min \u2264 30 ml/min , halve usual initial dose . patients creatinine clearance < 10 ml/min hemodialysis , recommended initial dose 2.5 mg ( 2.4 )",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            },
            {
                "text": "acute myocardial infarction (DOID:9408)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9408"
            },
            {
                "text": "myocardial infarction (DOID:5844)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5844"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "acute myocardial infarction",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_95409"
            }
        ]
    },
    "warningsAndPrecautions": "zestril available uncoated biconvex tablets bottles 90. strength color shape scored side 1/side 2 ndc 24979- 2.5 mg white round zestril 2\u00bd/135 238-07 5 mg pink capsule-shaped yes zestril/130 239-07 10 mg pink round zestril 10/131 240-07 20 mg pale brownish red round zestril 20/132 241-07 30 mg pale brownish red round zestril 30/133 242-07 40 mg yellow round zestril 40/134 243-07 store controlled room temperature , 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp ] . protect moisture , freezing excessive heat . dispense tight container .",
    "adverseReactions": "zestril contraindicated combination neprilysin inhibitor ( e.g . , sacubitril ) . administer zestril within 36 hours switching sacubitril/valsartan , neprilysin inhibitor [ ( 5.2 ) ] . zestril contraindicated patients : history angioedema hypersensitivity related previous treatment angiotensin converting enzyme inhibitor hereditary idiopathic angioedema co-administer aliskiren zestril patients diabetes [ ( 7.4 ) ] .",
    "indications_original": "Zestril is an angiotensin converting enzyme (ACE) inhibitor indicated for: Treatment of hypertension in adults and pediatric patients 6 years of age and older ( 1.1 ) Adjunct therapy for heart failure ( 1.2 ) Treatment of Acute Myocardial Infarction ( 1.3 )",
    "contraindications_original": "Hypertension: Initial adult dose is 10 mg once daily. Titrate up to 40 mg daily based on blood pressure response. Initiate patients on diuretics at 5 mg once daily ( 2.1 ) Pediatric patients with glomerular filtration rate > 30 mL/min/1.73m 2 : Initial dose in patients 6 years of age and older is 0.07 mg per kg (up to 5 mg total) once daily ( 2.1 ) Heart Failure: Initiate with 5 mg once daily. Increase dose as tolerated to 40 mg daily ( 2.2 ) Acute Myocardial Infarction (MI): Give 5 mg within 24 hours of MI. Followed by 5 mg after 24 hours, then 10 mg once daily ( 2.3 ) Renal Impairment: For patients with creatinine clearance \u2265 10 mL/min and \u2264 30 mL/min, halve usual initial dose. For patients with creatinine clearance < 10 mL/min or on hemodialysis, the recommended initial dose is 2.5 mg ( 2.4 )",
    "warningsAndPrecautions_original": "Zestril is available as uncoated biconvex tablets in bottles of 90.\n                  \n                     \n                        \n                           Strength\n                           Color\n                           Shape\n                           Scored\n                           Side 1/Side 2\n                           NDC 24979-\n                           \n                        \n                        \n                           2.5 mg\n                           White\n                           Round\n                           No\n                           ZESTRIL 2\u00bd/135\n                           238-07\n                           \n                        \n                        \n                           5 mg\n                           Pink\n                           Capsule-Shaped\n                           Yes\n                           ZESTRIL/130\n                           239-07\n                           \n                        \n                        \n                           10 mg\n                           Pink\n                           Round\n                           No\n                           ZESTRIL 10/131\n                           240-07\n                           \n                        \n                        \n                           20 mg\n                           Pale Brownish Red\n                           Round\n                           No\n                           ZESTRIL 20/132\n                           241-07\n                           \n                        \n                        \n                           30 mg\n                           Pale Brownish Red\n                           Round\n                           No\n                           ZESTRIL 30/133\n                           242-07\n                           \n                        \n                        \n                           40 mg\n                           Yellow\n                           Round\n                           No\n                           ZESTRIL 40/134\n                           243-07\n                           \n                        \n                     \n                  \n                  Store at controlled room temperature, 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [see USP].\u00a0 Protect from moisture, freezing and excessive heat.\u00a0 Dispense in a tight container.",
    "adverseReactions_original": "Zestril is contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). Do not\u00a0administer Zestril within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor\u00a0[\n                     see Warnings and Precautions (5.2)].\n                  Zestril is contraindicated in patients with:\n                  \n                     a history of angioedema or hypersensitivity related to previous treatment with an angiotensin converting enzyme inhibitor\n                     hereditary or idiopathic angioedema\n                  \n                  Do not co-administer aliskiren with ZESTRIL in patients with diabetes [see\n                     \n                         Drug Interactions (7.4)\n                     \n                     ].",
    "drug": [
        {
            "name": "Zestril",
            "drugbank_id": "https://go.drugbank.com/drugs/DB04573"
        }
    ]
}